Name | Number of supported studies | Average coverage | |
---|---|---|---|
epithelial cell | 6 studies | 25% ± 8% | |
astrocyte | 3 studies | 22% ± 5% | |
dendritic cell | 3 studies | 20% ± 2% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 3 studies | 37% ± 9% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
intestine | 100% | 1157.68 | 966 / 966 | 100% | 47.67 | 527 / 527 |
stomach | 100% | 806.04 | 359 / 359 | 100% | 48.03 | 286 / 286 |
ovary | 100% | 643.67 | 180 / 180 | 100% | 29.16 | 429 / 430 |
breast | 100% | 919.66 | 459 / 459 | 100% | 46.92 | 1115 / 1118 |
prostate | 100% | 983.46 | 245 / 245 | 100% | 34.00 | 500 / 502 |
esophagus | 100% | 1202.85 | 1445 / 1445 | 99% | 37.81 | 182 / 183 |
brain | 100% | 909.49 | 2631 / 2642 | 99% | 20.05 | 701 / 705 |
pancreas | 99% | 585.53 | 326 / 328 | 99% | 25.26 | 177 / 178 |
uterus | 100% | 764.62 | 170 / 170 | 99% | 38.36 | 453 / 459 |
lung | 99% | 695.71 | 571 / 578 | 100% | 32.06 | 1152 / 1155 |
thymus | 100% | 941.15 | 653 / 653 | 99% | 25.20 | 596 / 605 |
bladder | 100% | 908.52 | 21 / 21 | 98% | 33.19 | 494 / 504 |
kidney | 100% | 838.63 | 89 / 89 | 94% | 17.08 | 845 / 901 |
skin | 100% | 1108.00 | 1809 / 1809 | 91% | 20.37 | 428 / 472 |
adrenal gland | 100% | 1207.43 | 258 / 258 | 90% | 16.21 | 206 / 230 |
liver | 100% | 535.78 | 226 / 226 | 88% | 12.86 | 356 / 406 |
adipose | 100% | 842.80 | 1204 / 1204 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 100% | 25.64 | 29 / 29 |
spleen | 100% | 811.86 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 33.91 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 6.05 | 1 / 1 |
blood vessel | 100% | 846.06 | 1334 / 1335 | 0% | 0 | 0 / 0 |
muscle | 100% | 989.52 | 802 / 803 | 0% | 0 | 0 / 0 |
heart | 94% | 580.29 | 812 / 861 | 0% | 0 | 0 / 0 |
peripheral blood | 68% | 663.67 | 632 / 929 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 56% | 7.97 | 45 / 80 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0010165 | Biological process | response to X-ray |
GO_0010212 | Biological process | response to ionizing radiation |
GO_0140861 | Biological process | DNA repair-dependent chromatin remodeling |
GO_0045739 | Biological process | positive regulation of DNA repair |
GO_0006302 | Biological process | double-strand break repair |
GO_0006282 | Biological process | regulation of DNA repair |
GO_0051301 | Biological process | cell division |
GO_0007095 | Biological process | mitotic G2 DNA damage checkpoint signaling |
GO_1900227 | Biological process | positive regulation of NLRP3 inflammasome complex assembly |
GO_0044818 | Biological process | mitotic G2/M transition checkpoint |
GO_0070536 | Biological process | protein K63-linked deubiquitination |
GO_0006508 | Biological process | proteolysis |
GO_2000001 | Biological process | regulation of DNA damage checkpoint |
GO_0071479 | Biological process | cellular response to ionizing radiation |
GO_0000151 | Cellular component | ubiquitin ligase complex |
GO_0000922 | Cellular component | spindle pole |
GO_0005654 | Cellular component | nucleoplasm |
GO_0070531 | Cellular component | BRCA1-A complex |
GO_0070552 | Cellular component | BRISC complex |
GO_0005829 | Cellular component | cytosol |
GO_0000152 | Cellular component | nuclear ubiquitin ligase complex |
GO_0005737 | Cellular component | cytoplasm |
GO_0005634 | Cellular component | nucleus |
GO_0140492 | Molecular function | metal-dependent deubiquitinase activity |
GO_0004843 | Molecular function | cysteine-type deubiquitinase activity |
GO_0008237 | Molecular function | metallopeptidase activity |
GO_0046872 | Molecular function | metal ion binding |
GO_0061578 | Molecular function | K63-linked deubiquitinase activity |
GO_0031593 | Molecular function | polyubiquitin modification-dependent protein binding |
GO_0030234 | Molecular function | enzyme regulator activity |
GO_0005515 | Molecular function | protein binding |
Gene name | BRCC3 |
Protein name | BRCA1/BRCA2-containing complex subunit 3 Lys-63-specific deubiquitinase (EC 3.4.19.-) Lys-63-specific deubiquitinase BRCC36 (EC 3.4.19.-) (BRCA1-A complex subunit BRCC36) (BRCA1/BRCA2-containing complex subunit 3) (BRCA1/BRCA2-containing complex subunit 36) (BRISC complex subunit BRCC36) |
Synonyms | C6.1A BRCC36 CXorf53 |
Description | FUNCTION: Metalloprotease that specifically cleaves 'Lys-63'-linked polyubiquitin chains . Does not have activity toward 'Lys-48'-linked polyubiquitin chains . Component of the BRCA1-A complex, a complex that specifically recognizes 'Lys-63'-linked ubiquitinated histones H2A and H2AX at DNA lesions sites, leading to target the BRCA1-BARD1 heterodimer to sites of DNA damage at double-strand breaks (DSBs) . In the BRCA1-A complex, it specifically removes 'Lys-63'-linked ubiquitin on histones H2A and H2AX, antagonizing the RNF8-dependent ubiquitination at double-strand breaks (DSBs) . Catalytic subunit of the BRISC complex, a multiprotein complex that specifically cleaves 'Lys-63'-linked ubiquitin in various substrates . Mediates the specific 'Lys-63'-specific deubiquitination associated with the COP9 signalosome complex (CSN), via the interaction of the BRISC complex with the CSN complex . The BRISC complex is required for normal mitotic spindle assembly and microtubule attachment to kinetochores via its role in deubiquitinating NUMA1 . Plays a role in interferon signaling via its role in the deubiquitination of the interferon receptor IFNAR1; deubiquitination increases IFNAR1 activity by enhancing its stability and cell surface expression . Acts as a regulator of the NLRP3 inflammasome by mediating deubiquitination of NLRP3, leading to NLRP3 inflammasome assembly (By similarity). Down-regulates the response to bacterial lipopolysaccharide (LPS) via its role in IFNAR1 deubiquitination . Deubiquitinates HDAC1 and PWWP2B leading to their stabilization (By similarity). . FUNCTION: Metalloprotease that specifically cleaves 'Lys-63'-linked polyubiquitin chains. Component of the BRCA1-A complex, a complex that specifically recognizes 'Lys-63'-linked ubiquitinated histones H2A and H2AX at DNA lesions sites, leading to target the brca1-bard1 heterodimer to sites of DNA damage at double-strand breaks (DSBs). Catalytic subunit of the BRISC complex, a multiprotein complex that specifically cleaves 'Lys-63'-linked ubiquitin in various substrates. Mediates the specific 'Lys-63'-specific deubiquitination associated with the COP9 signalosome complex (CSN), via the interaction of the BRISC complex with the CSN complex. The BRISC complex is required for normal mitotic spindle assembly and microtubule attachment to kinetochores via its role in deubiquitinating NUMA1. . |
Accessions | H7C413 ENST00000330045.12 [P46736-2] ENST00000340647.8 [P46736-3] P46736 ENST00000453705.1 ENST00000411985.5 ENST00000369462.5 [P46736-1] A0A0A0MS96 ENST00000369459.6 [P46736-5] X6RJS7 ENST00000399026.1 |